Francesco Barletta1, Elio Mazzone2, Armando Stabile2, Simone Scuderi2, Giorgio Brembilla3, Mario de Angelis2, Giuseppe Ottone Cirulli2, Vito Cucchiara2, Giorgio Gandaglia2, R Jeffrey Karnes4, Morgan Roupret5, Francesco De Cobelli3, Francesco Montorsi2, Alberto Briganti2. 1. Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy. barletta.francesco@hsr.it. 2. Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy. 3. Department of Radiology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy. 4. Department of Urology, Mayo Clinic, Rochester, MN, USA. 5. Urology, GRC No 5, Predictive Onco-Urology, AP-HP, Hôpital Pitié Salpêtrière, Sorbonne Université, Paris, France.
Abstract
PURPOSE: We hypothesized that systematic biopsies (SBx) value for clinically significant PCa (csPCa) detection, in addition to mpMRI targeted biopsies (TBx), may vary significantly according to mpMRI index lesion (IL) characteristics. METHODS: We identified 1350 men with an mpMRI suspicious lesion (PI-RADS ≥ 3), defined as IL, who underwent TBx and SBx at three referral centres. The outcome was SBx added value in csPCa (grade group ≥ 2 PCa detected at SBx and missed by TBx) detection. To this aim, we performed multivariable logistic regression analyses (MVA). Furthermore, we explored the interaction between IL volume and SBx csPCa added value, across different PI-RADS categories, using lowess function. RESULTS: Overall, 569 (42%) men had csPCa at TBx and 78 (6%) csPCa were identified at SBx only. At MVA PSA (OR 0.90; p < 0.05) and IL volume (OR 0.58; p < 0.05) were associated with SBx csPCa added value. At interaction analyses, a nonlinear correlation between PI-RADS and SBx csPCa added value was identified with a decrease from roughly 10 to 4% followed by a substantial plateau at 1.2 ml and 0.6 ml for PI-RADS 3 and 4, respectively. For PI-RADS 5 lesions SBx csPCa added was constantly lower than 4%. CONCLUSIONS: Increasing IL volume in PI-RADS 3 and 4 lesions is associated with reduction in SBx csPCa added value. For diagnostic purposes, SBx could be omitted in men with IL larger than 1.2 ml and 0.6 ml for PI-RADS 3 and 4, respectively. Conversely, for PI-RADS 5, SBx csPCa added value was minimal regardless of IL volume.
PURPOSE: We hypothesized that systematic biopsies (SBx) value for clinically significant PCa (csPCa) detection, in addition to mpMRI targeted biopsies (TBx), may vary significantly according to mpMRI index lesion (IL) characteristics. METHODS: We identified 1350 men with an mpMRI suspicious lesion (PI-RADS ≥ 3), defined as IL, who underwent TBx and SBx at three referral centres. The outcome was SBx added value in csPCa (grade group ≥ 2 PCa detected at SBx and missed by TBx) detection. To this aim, we performed multivariable logistic regression analyses (MVA). Furthermore, we explored the interaction between IL volume and SBx csPCa added value, across different PI-RADS categories, using lowess function. RESULTS: Overall, 569 (42%) men had csPCa at TBx and 78 (6%) csPCa were identified at SBx only. At MVA PSA (OR 0.90; p < 0.05) and IL volume (OR 0.58; p < 0.05) were associated with SBx csPCa added value. At interaction analyses, a nonlinear correlation between PI-RADS and SBx csPCa added value was identified with a decrease from roughly 10 to 4% followed by a substantial plateau at 1.2 ml and 0.6 ml for PI-RADS 3 and 4, respectively. For PI-RADS 5 lesions SBx csPCa added was constantly lower than 4%. CONCLUSIONS: Increasing IL volume in PI-RADS 3 and 4 lesions is associated with reduction in SBx csPCa added value. For diagnostic purposes, SBx could be omitted in men with IL larger than 1.2 ml and 0.6 ml for PI-RADS 3 and 4, respectively. Conversely, for PI-RADS 5, SBx csPCa added value was minimal regardless of IL volume.
Authors: Veeru Kasivisvanathan; Armando Stabile; Joana B Neves; Francesco Giganti; Massimo Valerio; Yaalini Shanmugabavan; Keiran D Clement; Debashis Sarkar; Yiannis Philippou; David Thurtle; Jonathan Deeks; Mark Emberton; Yemisi Takwoingi; Caroline M Moore Journal: Eur Urol Date: 2019-05-24 Impact factor: 20.096
Authors: Juho T Eineluoto; Petrus Järvinen; Tuomas Kilpeläinen; Kanerva Lahdensuo; Inari Kalalahti; Kevin Sandeman; Tuomas Mirtti; Antti Rannikko Journal: Eur Urol Oncol Date: 2018-05-15
Authors: Armando Stabile; Francesco Giganti; Andrew B Rosenkrantz; Samir S Taneja; Geert Villeirs; Inderbir S Gill; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan Journal: Nat Rev Urol Date: 2019-07-17 Impact factor: 14.432
Authors: Armando Stabile; Paolo Dell'Oglio; Francesco De Cobelli; Antonio Esposito; Giorgio Gandaglia; Nicola Fossati; Giorgio Brembilla; Giulia Cristel; Gianpiero Cardone; Federico Deho'; Andrea Losa; Nazareno Suardi; Franco Gaboardi; Alessandro Del Maschio; Francesco Montorsi; Alberto Briganti Journal: Eur Urol Oncol Date: 2018-05-15
Authors: Paolo Dell'Oglio; Armando Stabile; Matteo Soligo; Giorgio Brembilla; Antonio Esposito; Giorgio Gandaglia; Nicola Fossati; Carlo Andrea Bravi; Federico Dehò; Francesco De Cobelli; Francesco Montorsi; R Jeffrey Karnes; Alberto Briganti Journal: Eur Urol Oncol Date: 2019-03-27
Authors: Olivier Wegelin; Leonie Exterkate; Marloes van der Leest; Johannes C Kelder; J L H Ruud Bosch; Jelle O Barentsz; Diederik M Somford; Harm H E van Melick Journal: Eur Urol Oncol Date: 2019-09-11
Authors: Luke P O'Connor; Alex Z Wang; Nitin K Yerram; Lori Long; Michael Ahdoot; Amir H Lebastchi; Sandeep Gurram; Johnathan Zeng; Stephanie A Harmon; Sherif Mehralivand; Maria J Merino; Howard L Parnes; Peter L Choyke; Joanna H Shih; Bradford J Wood; Baris Turkbey; Peter A Pinto Journal: Eur Urol Oncol Date: 2020-10-21
Authors: Michael Ahdoot; Andrew R Wilbur; Sarah E Reese; Amir H Lebastchi; Sherif Mehralivand; Patrick T Gomella; Jonathan Bloom; Sandeep Gurram; Minhaj Siddiqui; Paul Pinsky; Howard Parnes; W Marston Linehan; Maria Merino; Peter L Choyke; Joanna H Shih; Baris Turkbey; Bradford J Wood; Peter A Pinto Journal: N Engl J Med Date: 2020-03-05 Impact factor: 91.245